Lisette Nixon

Has grant

Senior Research Fellow; Deputy Head of Trial Management (Cancer)

Cardiff University
Country flagUnited Kingdom

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Lisette Nixon is a Senior Research Fellow and Deputy Head of Trial Management (Cancer) at Cardiff University, UK. Her research interests include the diagnostic accuracy of colon capsule endoscopy, the experiences of patients undergoing chemoradiotherapy for oesophageal cancer, and the efficacy of novel treatment protocols in various oncological settings. She has contributed to several significant studies, focusing on clinical trials and patient-centric outcomes in the field of cancer research.

Recent Grants

Grant: Open

ColoCap: determining the diagnostic accuracy of colon capsule endoscopy compared to standard colonoscopy in patients at risk of colorectal disease.

Open Date: 2024-04-01

Close Date: 2027-09-30

Grant: Open

SCC After Adjuvant radiotherapy in patients with high-risk primary cutaneous Squamous Cell Carcinoma AFTER surgery (SCC-AFTER): an open label, multicentre, two-arm phase III randomised Trial.

Open Date: 2023-01-01

Close Date: 2030-12-01

Grant: Close

PICCOS The PICCOS Trial (PIPAC in Cancers of the Colon, Ovaries and Stomach): A randomised controlled phase II trial in Colorectal, Ovarian and Stomach cancers to define the efficacy of Pressurised IntraPeritoneal Aerosolised Chemotherapy (PIPAC) in the management of peritoneal metastases.

Open Date: 2022-11-01

Close Date: 2026-10-01

Grant: Close

ABC-12: Exploring the microbiome in a first-line, randomised study of durvalumab in combination with cisplatin/gemcitabine versus placebo in combination with cisplatin/gemcitabine for patients with advanced biliary tract cancers.

Open Date: 2022-11-01

Close Date: 2026-10-01

Grant: Close

Rapid Protection: a proposal for an adaptive clinical trial of AZD7442 and Vaxzevria (AZD1222/ChAdOx1 nCoV-19) in immunosuppressed patients that are highly vulnerable to infection with SARS-CoV-2 virus.

Open Date: 2021-10-01

Close Date: 2024-02-01

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Sian Griffin

Consultant and Honorary Professor

Cardiff and Vale University Health Board

UNITED KINGDOM
View details

Maria Andreia Hawkins

University College London

UNITED KINGDOM
View details

Richard Adams

Professor

Cardiff University

UNITED KINGDOM
View details

Emiliano Spezi

Professor of Healthcare Engineering and Director of Research

Cardiff University

UNITED KINGDOM
View details

Timothy Stanley Maughan

Professor of Clinical Oncology, CRUK/MRC Oxford Institute for Radiation Oncology

University of Oxford

UNITED KINGDOM
View details

Chris Hurt

Cardiff University School of Medicine

UNITED KINGDOM
View details

Angela Casbard

-

UNITED KINGDOM
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.